Nanotherapeutics for Treating Neurodegenerative Disorders
Editat de Manish K. Chourasia, Shubhini A. Saraf, Yashwant Pathak, Mohini Chaurasiaen Limba Engleză Paperback – mai 2026
Whether seeking to unravel the complexities of mitochondrial dysfunction or to harness the potential of nanocarriers for targeted genetic material delivery, readers will find themselves equipped with the tools to navigate the forefront of neurotherapeutic innovation.
- Reviews the complexities of treatment strategies and the transformative role of nanotechnology in reshaping therapeutic interventions
- Offers a diverse array of insights, providing readers with invaluable knowledge across a spectrum of nanotherapeutic approaches
- Provides current updates on advanced, targets-based nanotherapeutics
Preț: 738.89 lei
Preț vechi: 777.79 lei
-5% Precomandă
Puncte Express: 1108
Preț estimativ în valută:
130.75€ • 152.48$ • 114.80£
130.75€ • 152.48$ • 114.80£
Carte nepublicată încă
Doresc să fiu notificat când acest titlu va fi disponibil:
Se trimite...
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780443336232
ISBN-10: 0443336237
Pagini: 350
Dimensiuni: 152 x 229 mm
Editura: ELSEVIER SCIENCE
ISBN-10: 0443336237
Pagini: 350
Dimensiuni: 152 x 229 mm
Editura: ELSEVIER SCIENCE
Cuprins
1. Concepts, types, and treatment strategies for neurodegenerative disorders
2. Transport mechanisms of the Blood-Brain Barrier
3. Need of nanotherapeutics against neurodegenerative disorders
4. Nanotechnology mediated drug delivery for addressing protein aggregation
5. Nanocarriers focusing on synuclein misfolding as a therapeutic target
6. Therapeutic potential of stem cells derived nanocarriers in neurological disorders
7. Emphasizing mitochondrial dysfunction and autophagy in the treatment of neurological disorders
8. Nanocarriers assisted delivery of genetic material for the treatment of neurodegenerative disorders
9. Nanotherapeutics targeting neuroinflammation
10. Nanocarriers mediated DNA repair mechanism against neurological disorders
11. Nanotherapy for targeted inhibition of PERK: Unravelling stress-induced endoplasmic reticulum kinase
12. Targeting microglial inhibition via nanotechnology: A strategy to halt protein degradation
13. Nanocarriers unveiling ferroptosis as a potential therapeutic target
14. Proteostasis maintenance through nanocarriers: Mitigating protein misfolding, mitochondrial impairment, and oxidative stress
15. Modulation of Hippo signaling pathway dysregulation through nanotechnology for neurodegenerative disorders
16. Nanocarriers modulating fibrinolytic pathways for the treatment of various neurological disorders
17. Targeting glial cells through nanotherapeutic strategies in neurological disorders
18. Oligodendrocytes as an emerging therapeutic target in neurological disorders
2. Transport mechanisms of the Blood-Brain Barrier
3. Need of nanotherapeutics against neurodegenerative disorders
4. Nanotechnology mediated drug delivery for addressing protein aggregation
5. Nanocarriers focusing on synuclein misfolding as a therapeutic target
6. Therapeutic potential of stem cells derived nanocarriers in neurological disorders
7. Emphasizing mitochondrial dysfunction and autophagy in the treatment of neurological disorders
8. Nanocarriers assisted delivery of genetic material for the treatment of neurodegenerative disorders
9. Nanotherapeutics targeting neuroinflammation
10. Nanocarriers mediated DNA repair mechanism against neurological disorders
11. Nanotherapy for targeted inhibition of PERK: Unravelling stress-induced endoplasmic reticulum kinase
12. Targeting microglial inhibition via nanotechnology: A strategy to halt protein degradation
13. Nanocarriers unveiling ferroptosis as a potential therapeutic target
14. Proteostasis maintenance through nanocarriers: Mitigating protein misfolding, mitochondrial impairment, and oxidative stress
15. Modulation of Hippo signaling pathway dysregulation through nanotechnology for neurodegenerative disorders
16. Nanocarriers modulating fibrinolytic pathways for the treatment of various neurological disorders
17. Targeting glial cells through nanotherapeutic strategies in neurological disorders
18. Oligodendrocytes as an emerging therapeutic target in neurological disorders